Literature DB >> 7882977

TGF-beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity.

K Krieglstein1, C Suter-Crazzolara, W H Fischer, K Unsicker.   

Abstract

The superfamily of transforming growth factors-beta (TGF-beta) comprises an expanding list of multifunctional proteins serving as regulators of cell proliferation and differentiation. Prominent members of this family include the TGF-beta s 1-5, activins, bone morphogenetic proteins and a recently discovered glial cell line-derived neurotrophic factor (GDNF). In the present study we demonstrate and compare the survival promoting and neuroprotective effects of TGF-beta 1, -2 and -3, activin A and GDNF for midbrain dopaminergic neurons in vitro. All proteins increase the survival of tyrosine hydroxylase-immunoreactive dopaminergic neurons isolated from the embryonic day (E) 14 rat mesencephalon floor to varying extents (TGF-beta s 2.5-fold, activin A and GDNF 1.6-fold). TGF-beta s, activin A and GDNF did not augment numbers of very rarely observed astroglial cells visualized by using antibodies to glial fibrillary acidic protein and had no effect on cell proliferation monitored by incorporation of BrdU. TGF-beta 1 and activin A protected dopaminergic neurons against N-methyl-4-phenylpiridinium ion toxicity. Reverse transcription-polymerase chain reaction (RT-PCR) analysis indicated that TGF-beta 2 mRNA, but not GDNF mRNA, is expressed in the E14 rat midbrain floor and in mesencephalic cultures. We conclude that TGF-beta s 1-3, activin A and GDNF share a neurotrophic capacity for developing dopaminergic neurons, which is not mediated by astroglial cells and not accompanied by an increase in cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7882977      PMCID: PMC398139          DOI: 10.1002/j.1460-2075.1995.tb07052.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  50 in total

1.  Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II.

Authors:  B Knusel; P P Michel; J S Schwaber; F Hefti
Journal:  J Neurosci       Date:  1990-02       Impact factor: 6.167

2.  Selective survival of neurons from chick embryo sensory ganglionic dissociates utilizing serum-free supplemented medium.

Authors:  J E Bottenstein; S D Skaper; S S Varon; G H Sato
Journal:  Exp Cell Res       Date:  1980-01       Impact factor: 3.905

3.  BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra.

Authors:  C Hyman; M Hofer; Y A Barde; M Juhasz; G D Yancopoulos; S P Squinto; R M Lindsay
Journal:  Nature       Date:  1991-03-21       Impact factor: 49.962

4.  Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists.

Authors:  L Turski; K Bressler; K J Rettig; P A Löschmann; H Wachtel
Journal:  Nature       Date:  1991-01-31       Impact factor: 49.962

5.  Isoform-specific effects of transforming growth factors-beta on degeneration of primary neuronal cultures induced by cytotoxic hypoxia or glutamate.

Authors:  J H Prehn; B Peruche; K Unsicker; J Krieglstein
Journal:  J Neurochem       Date:  1993-05       Impact factor: 5.372

6.  Activin is a nerve cell survival molecule.

Authors:  D Schubert; H Kimura; M LaCorbiere; J Vaughan; D Karr; W H Fischer
Journal:  Nature       Date:  1990-04-26       Impact factor: 49.962

7.  Transforming growth factor beta 1 is a potent survival factor for rat embryo motoneurons in culture.

Authors:  J C Martinou; A Le Van Thai; A Valette; M J Weber
Journal:  Brain Res Dev Brain Res       Date:  1990-03-01

8.  Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice.

Authors:  D Otto; K Unsicker
Journal:  J Neurosci       Date:  1990-06       Impact factor: 6.167

Review 9.  MPTP toxicity: implications for research in Parkinson's disease.

Authors:  I J Kopin; S P Markey
Journal:  Annu Rev Neurosci       Date:  1988       Impact factor: 12.449

10.  Basic fibroblast growth factor promotes the survival and development of mesencephalic neurons in culture.

Authors:  G Ferrari; M C Minozzi; G Toffano; A Leon; S D Skaper
Journal:  Dev Biol       Date:  1989-05       Impact factor: 3.582

View more
  69 in total

1.  Sonic hedgehog promotes the survival of specific CNS neuron populations and protects these cells from toxic insult In vitro.

Authors:  N Miao; M Wang; J A Ott; J S D'Alessandro; T M Woolf; D A Bumcrot; N K Mahanthappa; K Pang
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

2.  Effects of GDF5 overexpression on embryonic rat dopaminergic neurones in vitro and in vivo.

Authors:  David B O'Sullivan; Patrick T Harrison; Aideen M Sullivan
Journal:  J Neural Transm (Vienna)       Date:  2010-03-27       Impact factor: 3.575

3.  IL6 protects MN9D cells and midbrain dopaminergic neurons from MPP+-induced neurodegeneration.

Authors:  Björn Spittau; Xiaolai Zhou; Ming Ming; Kerstin Krieglstein
Journal:  Neuromolecular Med       Date:  2012-07-08       Impact factor: 3.843

4.  GABA and 5-HT chitosan nanoparticles decrease striatal neuronal degeneration and motor deficits during liver injury.

Authors:  J Shilpa; C S Paulose
Journal:  J Mater Sci Mater Med       Date:  2014-03-30       Impact factor: 3.896

5.  Neurons promote macrophage proliferation by producing transforming growth factor-beta2.

Authors:  A Dobbertin; P Schmid; M Gelman; J Glowinski; M Mallat
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

6.  Lipopolysaccharide-Induced Microglia Activation Promotes the Survival of Midbrain Dopaminergic Neurons In Vitro.

Authors:  Xiaolai Zhou; Björn Spittau
Journal:  Neurotox Res       Date:  2017-11-29       Impact factor: 3.911

7.  Glial cell line-derived neurotrophic factor (GDNF) gene expression in the human brain: a post mortem in situ hybridization study with special reference to Parkinson's disease.

Authors:  S Hunot; V Bernard; B Faucheux; F Boissière; E Leguern; C Brana; P P Gautris; J Guérin; B Bloch; Y Agid; E C Hirsch
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

8.  Sonic Hedgehog Protein : A Novel Approach to the Treatment of Neurodegenerative Disorders?

Authors:  K Pang; T D Ingolia
Journal:  CNS Drugs       Date:  1998-04       Impact factor: 5.749

9.  Glial cell line-derived neurotrophic factor requires transforming growth factor-beta for exerting its full neurotrophic potential on peripheral and CNS neurons.

Authors:  K Krieglstein; P Henheik; L Farkas; J Jaszai; D Galter; K Krohn; K Unsicker
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

10.  Delayed activin A administration attenuates tissue death after transient focal cerebral ischemia and is associated with decreased stress-responsive kinase activation.

Authors:  Shibani S Mukerji; Riley N Rainey; Jamie L Rhodes; Alison K Hall
Journal:  J Neurochem       Date:  2009-09-24       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.